Indeed, Kv1.3 (Mohr et al., 2019), Kv10.1 (García-Quiroz et al., 2019), and Kv11.1 (Wang et al., 2015; Breuer et al., 2019) have proven to be potential molecular targets for breast cancer therapy. This evidence concerns the gene KCNA3 and breast carcinoma.